PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Sodium citrate (Systemic)
Presentation Product Chemical substance Chapter Items dispensed
Sodium citrate 4g oral powder sachets
0704030J0AAAHAH
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders 210
Sodium citrate 4g granules for oral solution sachets
0704030J0AAAIAI
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders 209
Sodium citrate 1.25g/5ml oral solution
0704030J0AAALAL
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 1.47g/5ml oral solution
0704030J0AAARAR
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 1.5g/5ml oral solution
0704030J0AAAUAU
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 294.1mg/5ml oral solution
0704030J0AAAKAK
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 441.15mg/5ml oral solution
0704030J0AAAJAJ
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 441mg/5ml oral solution
0704030J0AAANAN
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 450mg/5ml oral solution
0704030J0AAASAS
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Sodium citrate 588.2mg/5ml oral solution
0704030J0AAAPAP
Sodium citrate (Systemic) Sodium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.